Mirae Asset Global Etfs Holdings Ltd. Guardant Health, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 64,618 shares of GH stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,618
Previous 56,945
13.47%
Holding current value
$1.97 Million
Previous $1.64 Million
9.91%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
323Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$357 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$343 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$309 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$212 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$183 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.12B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...